Artwork

Kandungan disediakan oleh CRC Group. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh CRC Group atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

The Skinny on GLP-1s for Healthcare Industry Risks

24:44
 
Kongsi
 

Manage episode 445801726 series 2822097
Kandungan disediakan oleh CRC Group. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh CRC Group atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to resumes@crcgroup.com today!

  continue reading

Bab

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

97 episod

Artwork
iconKongsi
 
Manage episode 445801726 series 2822097
Kandungan disediakan oleh CRC Group. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh CRC Group atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Ever wondered how the latest advancements in GLP-1 medications are revolutionizing the treatment of diabetes and obesity? Join us for an insightful conversation with healthcare brokers Scott Scheiblin and Chip Wenges as they unravel the complexities and opportunities these groundbreaking drugs bring to healthcare providers. You'll discover the hidden pitfalls of improper prescribing practices, the looming threat of regulatory scrutiny over compounded medications, and the challenges posed by insurers limiting coverage to branded versions. As the demand for GLP-1s skyrockets, we discuss the implications and potential repercussions that could follow.

Visit REDYIndex.com for critical pricing analysis and a snapshot of the marketplace.

Do you want to take your career to the next level? Join #TeamCRC to get access to best-in-class tools, data, exclusive programs, and more! Send your resume to resumes@crcgroup.com today!

  continue reading

Bab

1. The Skinny on GLP-1s for Healthcare Industry Risks (00:00:00)

2. Can you briefly explain what GLP-1 medications are and why their use is exploding right now? (00:02:03)

3. Walk us through some of the key risks for healthcare providers that are jumping into the GLP-1 fray. (00:03:32)

4. We’ve seen some FDA advisories around compounded versions of GLP-1s. How do you see this impacting providers? (00:04:38)

5. Are insurers pulling back? (00:06:00)

6. Do you anticipate litigation becoming a bigger concern for healthcare providers? (00:08:38)

7. What steps should healthcare providers be taking right now to mitigate these risks? (00:10:47)

8. Why is Team CRC the right partner? (00:18:41)

9. Rapid Fire! (00:20:36)

97 episod

Semua episod

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas
Dengar rancangan ini semasa anda meneroka
Main